129 related articles for article (PubMed ID: 11581176)
1. CD44 stimulation down-regulates Fas expression and Fas-mediated apoptosis of lung cancer cells.
Yasuda M; Tanaka Y; Fujii K; Yasumoto K
Int Immunol; 2001 Oct; 13(10):1309-19. PubMed ID: 11581176
[TBL] [Abstract][Full Text] [Related]
2. CD44 is the physiological trigger of Fas up-regulation on rheumatoid synovial cells.
Fujii K; Fujii Y; Hubscher S; Tanaka Y
J Immunol; 2001 Aug; 167(3):1198-203. PubMed ID: 11466334
[TBL] [Abstract][Full Text] [Related]
3. Functional proteomic screen identifies a modulating role for CD44 in death receptor-mediated apoptosis.
Hauptschein RS; Sloan KE; Torella C; Moezzifard R; Giel-Moloney M; Zehetmeier C; Unger C; Ilag LL; Jay DG
Cancer Res; 2005 Mar; 65(5):1887-96. PubMed ID: 15753387
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronan induces cell death in activated T cells through CD44.
Ruffell B; Johnson P
J Immunol; 2008 Nov; 181(10):7044-54. PubMed ID: 18981124
[TBL] [Abstract][Full Text] [Related]
5. CD44: functional relevance to inflammation and malignancy.
Yasuda M; Nakano K; Yasumoto K; Tanaka Y
Histol Histopathol; 2002; 17(3):945-50. PubMed ID: 12168806
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus infection of T cells inhibits proliferation and enhances fas-mediated apoptosis by down-regulating the expression of CD44 splicing variant 6.
Kondo Y; Machida K; Liu HM; Ueno Y; Kobayashi K; Wakita T; Shimosegawa T; Lai MM
J Infect Dis; 2009 Mar; 199(5):726-36. PubMed ID: 19199548
[TBL] [Abstract][Full Text] [Related]
7. Early detachment of colon carcinoma cells during CD95(APO-1/Fas)-mediated apoptosis. I. De-adhesion from hyaluronate by shedding of CD44.
Günthert AR; Sträter J; von Reyher U; Henne C; Joos S; Koretz K; Moldenhauer G; Krammer PH; Möller P
J Cell Biol; 1996 Aug; 134(4):1089-96. PubMed ID: 8769429
[TBL] [Abstract][Full Text] [Related]
8. CTL adoptive immunotherapy concurrently mediates tumor regression and tumor escape.
Liu K; Caldwell SA; Greeneltch KM; Yang D; Abrams SI
J Immunol; 2006 Mar; 176(6):3374-82. PubMed ID: 16517705
[TBL] [Abstract][Full Text] [Related]
9. Targeting dendritic cells with CD44 monoclonal antibodies selectively inhibits the proliferation of naive CD4+ T-helper cells by induction of FAS-independent T-cell apoptosis.
Termeer C; Averbeck M; Hara H; Eibel H; Herrlich P; Sleeman J; Simon JC
Immunology; 2003 May; 109(1):32-40. PubMed ID: 12709015
[TBL] [Abstract][Full Text] [Related]
10. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R; Egle A; Villunger A
Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
[TBL] [Abstract][Full Text] [Related]
11. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
Uslu R; Borsellino N; Frost P; Gárban H; Ng CP; Mizutani Y; Belldegrun A; Bonavida B
Clin Cancer Res; 1997 Jun; 3(6):963-72. PubMed ID: 9815772
[TBL] [Abstract][Full Text] [Related]
12. Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicity.
Frost P; Ng CP; Belldegrun A; Bonavida B
Cell Immunol; 1997 Aug; 180(1):70-83. PubMed ID: 9316641
[TBL] [Abstract][Full Text] [Related]
13. Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer.
Bennett MW; O'connell J; O'sullivan GC; Roche D; Brady C; Kelly J; Collins JK; Shanahan F
Gut; 1999 Feb; 44(2):156-62. PubMed ID: 9895372
[TBL] [Abstract][Full Text] [Related]
14. Role of CD44 in activation-induced cell death: CD44-deficient mice exhibit enhanced T cell response to conventional and superantigens.
McKallip RJ; Do Y; Fisher MT; Robertson JL; Nagarkatti PS; Nagarkatti M
Int Immunol; 2002 Sep; 14(9):1015-26. PubMed ID: 12202399
[TBL] [Abstract][Full Text] [Related]
15. Expression in cytotoxic T lymphocytes of a single-chain anti-carcinoembryonic antigen antibody. Redirected Fas ligand-mediated lysis of colon carcinoma.
Darcy PK; Kershaw MH; Trapani JA; Smyth MJ
Eur J Immunol; 1998 May; 28(5):1663-72. PubMed ID: 9603473
[TBL] [Abstract][Full Text] [Related]
16. Oral cancer cell lines can use multiple ligands, including Fas-L, TRAIL and TNF-alpha, to induce apoptosis in Jurkat T cells: possible mechanisms for immune escape by head and neck cancers.
Kassouf N; Thornhill MH
Oral Oncol; 2008 Jul; 44(7):672-82. PubMed ID: 17996489
[TBL] [Abstract][Full Text] [Related]
17. Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Bhattacharya-Chatterjee M
Immunology; 2006 Aug; 118(4):483-96. PubMed ID: 16895556
[TBL] [Abstract][Full Text] [Related]
18. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.
Rivoltini L; Radrizzani M; Accornero P; Squarcina P; Chiodoni C; Mazzocchi A; Castelli C; Tarsini P; Viggiano V; Belli F; Colombo MP; Parmiani G
J Immunol; 1998 Aug; 161(3):1220-30. PubMed ID: 9686582
[TBL] [Abstract][Full Text] [Related]
19. CD44 binds a chondroitin sulfate proteoglycan, aggrecan.
Fujimoto T; Kawashima H; Tanaka T; Hirose M; Toyama-Sorimachi N; Matsuzawa Y; Miyasaka M
Int Immunol; 2001 Mar; 13(3):359-66. PubMed ID: 11222505
[TBL] [Abstract][Full Text] [Related]
20. Restoration of CD44S in non-small cell lung cancer cells enhanced their susceptibility to the macrophage cytotoxicity.
Takahashi K; Takahashi F; Hirama M; Tanabe KK; Fukuchi Y
Lung Cancer; 2003 Aug; 41(2):145-53. PubMed ID: 12871777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
